Clinical Trial Update: A Study of PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating PRO95780 in combination with Rituximab in patients with Non-Hodgkin lymphoma that progressed after prior Rituximab therapy; the trial s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• PRO95780
• Rituxan (rituximab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED